Literature DB >> 14667136

A CAG repeat polymorphism in the androgen receptor gene is associated with reduced bone mass and increased risk of osteoporotic fractures.

B L Langdahl1, L Stenkjaer, M Carstens, C L Tofteng, E F Eriksen.   

Abstract

Osteoporosis is a common disease with a strong genetic component. Hypogonadism results in low bone mass and it increases significantly the risk of osteoporosis in both sexes. The estrogen and androgen receptor genes are therefore strong candidates for mediating the genetic influence on bone mass and risk of osteoporosis. A CAG repeat in the first exon of the androgen receptor (AR) is associated with reduced transcriptional activity of the AR. We therefore examined whether this CAG repeat polymorphism is associated with changes in bone mass and risk of osteoporotic fractures in 284 osteoporotic patients with vertebral fractures and 327 normal individuals. The number of CAG repeats varied between 13 and 30 in men and between 7 and 34 in women. The short and long alleles comprised 19.2 +/- 2.5 and 19.0 +/- 2.3 repeats (ns) and 22.7 +/- 2.4 and 21.9 +/- 2.4 (P < 0.01) in women with vertebral fractures and normal women, respectively. This difference was also reflected in the average number of CAG repeats: 21.0 +/- 2.0 in osteoporotic women vs. 20.5 +/- 2.0 in normal women (P < 0.05). 54.8% of women with osteoporotic fractures vs. 45.9% of normal women had average number of CAG repeats of 21 and more (chi2 = 3.11, P = 0.08). Logistic regression analyses revealed that both the average number of CAG repeats and the length of the long allele were significant predictors of osteoporotic fractures in women (P < 0.05 and P < 0.01, respectively). Men with vertebral fractures had 20.0 +/- 2.8 CAG repeats compared with 20.7 +/- 2.5 CAG repeats in normal men (ns). Linear regression analysis revealed that the length of the long allele was negatively correlated with BMD of the lumbar spine (P < 0.05) and femoral neck (P < 0.05) in women. In men, linear regression analyses demonstrated that BMD of the lumbar spine (P < 0.05), femoral neck (P < 0.05) and total hip (P < 0.05) was positively correlated with length of the CAG repeat polymorphism. In conclusion, we have demonstrated that the CAG repeat polymorphism in the first exon of the AR gene is associated with reduced bone mass and increased risk of osteoporotic fractures in women.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14667136     DOI: 10.1007/s00223-002-0019-8

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  10 in total

1.  Association of polymorphisms of the androgen receptor and klotho genes with bone mineral density in Japanese women.

Authors:  Yoshiji Yamada; Fujiko Ando; Naoakira Niino; Hiroshi Shimokata
Journal:  J Mol Med (Berl)       Date:  2004-11-04       Impact factor: 4.599

Review 2.  Molecular genetic studies of gene identification for osteoporosis: a 2004 update.

Authors:  Yong-Jun Liu; Hui Shen; Peng Xiao; Dong-Hai Xiong; Li-Hua Li; Robert R Recker; Hong-Wen Deng
Journal:  J Bone Miner Res       Date:  2006-10       Impact factor: 6.741

3.  Effects of testosterone replacement therapy on bone metabolism in male post-surgical hypogonadotropic hypogonadism: focus on the role of androgen receptor CAG polymorphism.

Authors:  G Tirabassi; N delli Muti; A Gioia; A Biagioli; A Lenzi; G Balercia
Journal:  J Endocrinol Invest       Date:  2014-01-24       Impact factor: 4.256

4.  Preeclampsia and androgen receptor gene CAG repeat length: results from both children and women.

Authors:  Tanja Saarela; Jarmo Jääskeläinen; Sirpa Tenhola; Raimo Voutilainen; Seppo Heinonen
Journal:  J Assist Reprod Genet       Date:  2005-08       Impact factor: 3.412

5.  Androgen receptor CAG repeat size is associated with stress fracture risk: a pilot study.

Authors:  Ran Yanovich; Roni Milgrom; Eitan Friedman; Daniel S Moran
Journal:  Clin Orthop Relat Res       Date:  2011-02-15       Impact factor: 4.176

6.  Genetic determinants of osteoporosis: common bases to cardiovascular diseases?

Authors:  Francesca Marini; Maria Luisa Brandi
Journal:  Int J Hypertens       Date:  2010-03-25       Impact factor: 2.420

7.  Bone mass and the CAG and GGN androgen receptor polymorphisms in young men.

Authors:  Amelia Guadalupe-Grau; Francisco Germán Rodríguez-González; Jesús Gustavo Ponce-González; Cecilia Dorado; Hugo Olmedillas; Teresa Fuentes; Jorge Pérez-Gómez; Joaquín Sanchís-Moysi; Bonifacio Nicolás Díaz-Chico; José A L Calbet
Journal:  PLoS One       Date:  2010-07-12       Impact factor: 3.240

Review 8.  Influence of CAG Repeat Polymorphism on the Targets of Testosterone Action.

Authors:  Giacomo Tirabassi; Angelo Cignarelli; Sebastio Perrini; Nicola Delli Muti; Giorgio Furlani; Mariagrazia Gallo; Francesco Pallotti; Donatella Paoli; Francesco Giorgino; Francesco Lombardo; Loredana Gandini; Andrea Lenzi; Giancarlo Balercia
Journal:  Int J Endocrinol       Date:  2015-09-02       Impact factor: 3.257

Review 9.  A comprehensive overview on osteoporosis and its risk factors.

Authors:  Farkhondeh Pouresmaeili; Behnam Kamalidehghan; Maryam Kamarehei; Yong Meng Goh
Journal:  Ther Clin Risk Manag       Date:  2018-11-06       Impact factor: 2.423

10.  Androgen receptor polyglutamine repeat number: models of selection and disease susceptibility.

Authors:  Calen P Ryan; Bernard J Crespi
Journal:  Evol Appl       Date:  2012-06-11       Impact factor: 5.183

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.